#United States #Health Equity #Cancer Prevention #Washington D.C. #NCCN

Introduction

On October 5-6, 2026, the National Comprehensive Cancer Network® (NCCN) convened a significant two-day summit in Washington D.C. dedicated to enhancing access to essential cancer prevention and screening strategies. The summit drew insightful discussions from leading experts within the National Cancer Institute (NCI), the Centers for Disease Control and Prevention (CDC), and various patient advocacy groups. With a strong focus on both population-wide policies and individual solutions, attendees explored updates in cancer prevention knowledge, emphasizing how to effectively lower cancer risks and promote early detection.

Urgency of the Topic

In today's healthcare landscape, the need for robust cancer prevention methods is more pressing than ever. Chyke Doubeni, MD, MPH, underscored this urgency by stating, "Established prevention and screening strategies have the power to eliminate nearly half of all cancer deaths." However, persistent barriers remain that hinder many from accessing these vital resources. The summit focused on bridging the gap between the advances in cancer detection technology and the real-world accessibility of these innovations—particularly for marginalized populations.

Keynote Speakers and Their Insights

The summit featured keynote presentations from prominent figures like Anthony Letai, MD, PhD, and Captain Jacqueline Miller, MD. Their contributions highlighted the transformative potential of cancer-screening innovations and how equitable access is essential to maximize benefits.

Engaging Communities

Advocates and experts also emphasized the importance of community engagement in shaping health systems. Darcie Green from Latinas Contra Cancer remarked on the vital need for excellent care and patient navigation, emphasizing that closing the gap in accessibility involves reaching out to patients and the communities they represent. In addition, Jody Hoyos from the Prevent Cancer Foundation noted a paradigm shift in cancer care from merely reacting to cancer after diagnosis to proactively managing risk and expanding screening capabilities.

Strategies for Improvement

The summit was split into two main focus days: the first concentrated on broad strategies to enhance prevention, including infrastructure, tobacco cessation, vaccinations, blood-based tests, and the role of artificial intelligence in improving healthcare delivery. The second day scrutinized systems-level solutions aimed at tailoring individual screening needs, particularly for high-risk groups.

Lisa Schlager from FORCE emphasized that cancer risk profiles are unique—accounting for factors like age, genetics, and lifestyle is crucial for developing personalized screening strategies. She stated, "Public policies must evolve to ensure patients can access appropriate interventions tailored to their needs, ultimately enhancing outcomes and reducing healthcare costs."

Addressing Barriers to Access

Key discussions also revolved around the obstacles that hinder screening access, especially for underserved populations. Brandon Leonard from LUNGevity Foundation articulated the importance of seamless continuity of care, from initial screenings to follow-up diagnostics and treatment transitions. The emphasis on policy changes to make screening universally accessible was echoed throughout the summit’s sessions.

Additionally, disparities in access—particularly for LGBTQIA+ communities—were elucidated by Scout, PhD, who mentioned the deepening mistrust in medical systems. He indicated that simple initiatives like inclusive signage within healthcare facilities could make a substantial difference in accessibility and comfort levels among diverse patient populations.

The Path Forward

Ernest Hawk, MD, from the MD Anderson Cancer Center, spoke about the rapid advancements in cancer prevention methodologies and how translating scientific progress into practical solutions is necessary to save lives. The collective aim is to utilize innovations—like multicancer detection tests—while carefully weighing their potential risks and benefits. As Dr. Rodriguez highlighted, individuals are eager for actionable advice on risk reduction once they receive their cancer risk information.

Conclusion

The summit culminated with a commitment to host future events, such as the upcoming Patient Advocacy Summit on December 3, 2026, focused on advancing family-centered cancer care. The collaboration among leading cancer care organizations, healthcare professionals, and patient advocates signifies a collective drive toward addressing disparities in cancer prevention and ensuring equitable, accessible care for all individuals affected by cancer. For more information, visit NCCN.org/summits.

About NCCN

The National Comprehensive Cancer Network® (NCCN) is a not-for-profit alliance of top cancer centers committed to providing high-quality, evidence-based cancer care. The organization's guidelines are considered a gold standard in clinical practice and public policy regarding cancer management. For additional details and resources, visit NCCN.org.